| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology 2001; 40: 1056-1059
© 2001 British Society for Rheumatology
Original Papers |
High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjögren's syndrome
Systemic Autoimmune Diseases Unit and
1 Department of Immunology, Hospital Clínic, Department of Medicine, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), School of Medicine, University of Barcelona, Barcelona, Spain and
2 Pharmaceutical Research Institute, Bristol-Myers Squibb, Seattle, WA, USA
Objective. To determine the existence of circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjögren's syndrome (SS), and to analyse the correlation with clinical and immunological features of SS.
Methods. Ninety consecutive patients with primary SS were studied. All patients fulfilled four or more of the European diagnostic criteria for SS. sCD5 and sCD6 levels were determined using a specific enzyme-linked immunosorbent assay (ELISA) developed in our laboratory.
Results. Detectable levels of sCD5 were found in 39 (43%) SS patients. The mean±standard error values of sCD5 were 3.5±0.5 ng/ml for patients with SS and 1.9±0.1 ng/ml for healthy blood donors (P<0.001). We found higher levels of sCD5 in patients with hypocomplementaemia (6.5 vs 3.5 ng/ml, P=0.03) and cryoglobulinaemia (6.9 vs 2.6 ng/ml, P=0.001). On the other hand, detectable levels of sCD6 were found in 60 (67%) SS patients. The mean±standard error values of sCD6 were 25.5±7.8 ng/ml in SS patients and 5.27±1.40 ng/ml in healthy blood donors (P=0.01). When the sCD6 levels were compared according to the presence or absence of immunological features, patients with cryoglobulinaemia showed higher levels of circulating sCD6 (77.3 vs 17 ng/ml, P=0.01) than those without cryoglobulinaemia.
Conclusion. Patients with primary SS showed higher levels of circulating sCD5 and sCD6 when compared with controls. Moreover, the existence of some immunological features (hypocomplementaemia and cryoglobulinaemia) was associated with high levels of both soluble scavenger receptors. These facts may reflect an enhanced lymphocytic activation in patients with primary SS.
KEY WORDS: Soluble CD5, Soluble CD6, Primary Sjögren's syndrome.
Correspondence to: J. Font, Unitat de Malalties Autoimmunes Sistèmiques, Hospital Clínic, C/Villarroel 170, 08036 Barcelona, Spain
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Z.-Q. Wang, W.-M. Xing, H.-H. Fan, K.-S. Wang, H.-K. Zhang, Q.-W. Wang, J. Qi, H.-M. Yang, J. Yang, Y.-N. Ren, et al. The Novel Lipopolysaccharide-Binding Protein CRISPLD2 Is a Critical Serum Protein to Regulate Endotoxin Function J. Immunol., November 15, 2009; 183(10): 6646 - 6656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-R. Sarrias, M. Farnos, R. Mota, F. Sanchez-Barbero, A. Ibanez, I. Gimferrer, J. Vera, R. Fenutria, C. Casals, J. Yelamos, et al. CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock PNAS, July 10, 2007; 104(28): 11724 - 11729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Gimferrer, M. Calvo, M. Mittelbrunn, M. Farnos, M. R. Sarrias, C. Enrich, J. Vives, F. Sanchez-Madrid, and F. Lozano Relevance of CD6-Mediated Interactions in T Cell Activation and Proliferation J. Immunol., August 15, 2004; 173(4): 2262 - 2270. [Abstract] [Full Text] [PDF]
|
|